FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20242474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Niccolò Bianchi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland. Hauptthemen laut MEDLINE: Receptors, Immunologic, Lymphocyte Activation, Memory T Cells, Immunologic Memory. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Ceresio Foundation Lugano, Switzerland, Italian Ministry of Health.
Abstract (Originalsprache)
Genetic variants in the FCRL3 gene are linked to autoimmune disorders. However, the functional properties of FCRL3-expressing T lymphocytes, and the regulation and functional impact of FCRL3 expression remain understudied. Here, we performed a multiomic and functional analysis of human T lymphocytes expressing FCRL3. FCRL3 expression correlated with reduced capacity of T cells to undergo activation and was accompanied by functional specialization toward a cytotoxic phenotype, resembling cytotoxic CD4+ T lymphocytes and CD8+ effector memory TEMRA cells. FCRL3 expression was induced upon repetitive TCR engagement, and sufficed to attenuate T cell responses, indicating a role as a negative regulator of the activation of differentiated T cell subsets with high cytotoxic capacity. Mechanistically, the cytoplasmic domain of FCRL3 engaged inhibitory molecules, suggesting a direct role in limiting activating signals. Overall, our study establishes FCRL3 as a functional immunoregulatory receptor that restrains the activation of highly specialized human memory T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.
- Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
- Institute for Microbiology, ETH Zurich , Zurich, Switzerland.
ORCID-Profile: Niccolò Bianchi, Elena Foli, Mehrpouya Mostanfar, Roberta Marzi, Mara Cetty Spinella, Sara Polletti, Matteo Pecoraro, Antonino Cassotta, Roshan Thakur, David Jarrossay, Federica Sallusto, Gioacchino Natoli, Silvia Monticelli
Förderung
- Swiss National Science Foundation
- Ceresio Foundation Lugano, Switzerland
- Italian Ministry of Health
- Istituto Europeo di Oncologia
- Scientific Institute for Research, Hospitalization and Healthcare
Zitieren
APA
Bianchi, N., Foli, E., Mostanfar, M., Marzi, R., Spinella, M. C., Polletti, S., Pecoraro, M., Cassotta, A., Thakur, R., Jarrossay, D., Sallusto, F., Natoli, G., & Monticelli, S. (2026). FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20242474
Vancouver
Bianchi N, Foli E, Mostanfar M, Marzi R, Spinella MC, Polletti S, et al. FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20242474
BibTeX
@article{Bianchi2026,
author = {Bianchi, Niccolò and Foli, Elena and Mostanfar, Mehrpouya and Marzi, Roberta and Spinella, Mara Cetty and Polletti, Sara and Pecoraro, Matteo and Cassotta, Antonino and Thakur, Roshan and Jarrossay, David and Sallusto, Federica and Natoli, Gioacchino and Monticelli, Silvia},
title = {FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20242474}
}
EUVIMED